Work

OS-117 Assessment of resmetirom efficacy (80 mg vs. 100 mg) stratified by baseline body mass index and weight in patients from the MAESTRO-NASH trial

Year: 2024

Type: conference-abstract

Source: Journal of Hepatology

DOI: 10.1016/s0168-8278(24)00558-0

Authors: Jörn M Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Stephen A. Harrison, Mazen Noureddin

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4399462230

Cites:

Cited by: 2

Related to: 10